In this setting, HIF stabilization through pharmacological PHD inhibitors enhances kidney recovery in several types of AKI, including AKI caused by nephrotoxicity and renal reperfusion, the most common causes of AKI. This evidence concerns the gene PDC and acute kidney injury.